Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist

Under the agreement, Caresyntax will design and operate a multi-phase real-world evidence program across a network of partner surgical facilities

← Previous
Next →
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTERST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY
  • HEALTH / LIFESTYLE
  • ARTICLES OF INTERST
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY

© 2026 All rights Reserved. Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.